BIFIDO Co., Ltd.

₩2,375As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:238200Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (20.80%)
Div yield —
ROE 3.83%
Pharmaceutical Preparations
Beta (5Y) 0.90
PE TTM 10.49
TSR TTM (34.66%)
Mkt cap ₩19.43B
ROIC (1.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,802
17.98%
(57.02%)
Hold 9|7|11|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
31.70
30.91
34.48
34.40
19.83%
5.50%
14.04%
11.08%
Revenue₩B
2.201
2.164
2.127
2.196
6.41%
6.25%
6.90%
4.43%
Peers (US$14.32M)
Cap (US$)
PE
14.50M
11.31x
Capital
TTM
5Y
10Y
Leveragex
0.319
—
—
EBIT/Intx
0.314
0.401
0.319
Own earn%
(297.38)
(31.48)
(26.90)
Sh yield%
18.20
16.74
21.31
Owners
Insiders/Inst%
8.75
49.30
Short interest%
3.17
SBC / revenue%
3.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
2